CRF Bracket Supports Remote Consenting for Virtual Clinical Studies with Latest Release of its Integrated eConsent Solution

TrialConsent extends informed consent to virtual studies for Sites, Sponsors and Patients

London, UK and Philadelphia, USA – March 19, 2019:  CRF Bracket announced a new release of TrialConsent®, the latest version of its revolutionary eConsent solution, with enhanced capabilities to support remote consenting in virtual clinical trials. With the industry embracing electronic platforms and studies including virtual trial components increasing, this latest iteration of TrialConsent is poised to support remote consenting and at-home consenting by patients.

Ideally suited to the remote trial model, TrialConsent designs, collects, and manages the informed consent process when delivered both at site visit or remotely at home, and is the only eConsent solution that can serve as either a standalone solution or integrate with eCOA and enhance patient engagement on the same platform. Exclusive TrialConsent features provide patients with a secure password-protected login account that enables them to save progress whether they are at home or at the site.

“The continually increasing demand for solutions like TrialConsent underscores the accelerating demand across the life science industry for more integration of capable, reliable electronic processes for a more patient-centered approach,” said Jeff Lee, Product Lead, Patient Engagement and eConsent at CRF Bracket. “In addition to uniquely supporting remote consent in virtual trials, TrialConsent seamlessly complements CRF Bracket’s suite of patient-centric eClinical solutions, where eConsent, eCOA, patient engagement and ePRO combine to provide a total patient centric experience.”

By design, a virtual trial – also referred to as a direct-to-patient, site-less and remote study – maximizes patient availability and enrollment in a clinical study. Supported by the right eClinical solution, these virtual studies can greatly increase access to hard-to- reach patient populations (i.e. new geographies and remote areas).  This can be particularly important in rare diseases research, for example, where patient recruitment is challenging due to the geographic dispersion of potential participants.

TrialConsent underpins patient centricity for virtual studies, enabling the onboarding of patients with reduced or no site visits, more time to evaluate the study information and consent form at home, and the opportunity to involve family and friends in the decision to participate. Fewer visits and less frequent travel for patients consequently reduces costs incurred by sponsors and has the potential to keep subjects connected with the study. The virtual trial model, supported by technology that offers patients a simple experience, also allows the patient to perform study requirements independently from the site, which benefits those with mobility issues, such as the elderly, or those living in rural areas.

To learn more about CRF Bracket’s solutions for eConsent, eCOA, Patient Engagement, IRT, Clinical Supply Management, and Endpoint Quality scientific and data support services, visit www.crfhealth.com and www.bracketglobal.com.

*****************

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world.

To learn more visit http://www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

CRF Bracket Welcomes Susie Robinson as Chief People Officer

Strategic Senior Appointment Spearheads Compelling Work Culture for Continued Success

LONDON, UK & PHILADELPHIA, PA – MARCH 07, 2019: CRF Bracket today announced that Susie Robinson will join the company as Chief People Officer. Susie brings to CRF Bracket more than two decades of human resources leadership with an impressive track record of success as a global HR executive. She has overseen talent management and human capital strategy during critical periods of strategic expansion for companies including B. Braun, Dow Jones and Lumeris, and has a wealth of experience in multiple sectors, including media, digital marketing, business information services, healthcare tech and life sciences. Responsible for recruitment, retention and workplace culture, Susie will create world-class people programs and practices to support CRF Bracket’s more than 1500 employees worldwide.

As a fast-growing company with an emerging and active culture, our ability to succeed is a reflection of the people who choose to spend their time with us, so we place great importance on investing in, and developing, exceptional people,” said Mike Nolte, CEO, CRF Bracket. “Adding Susie to our team is a pivotal moment because she brings a powerful combination of strategic insight and partnership that will help us move more urgently to shape the future of this company, inside and out.

Commenting on her appointment, Susie said: “I am here for the same reason I think most people join CRF Bracket — to help our customers change the world with life-changing medicines using technology that patients enjoy. Our mission will be brought to life by connecting our unique legacy with our aspiration to nurture a culture of innovation: respecting our traditions and keeping an urgent focus on bringing great ideas to market that will take our company and our customers to a new level. I knew there was no better company to join if I wanted to make an impact, and it is an honor for me to lead the people function for CRF Bracket.”

Susie graduated from California State University at Fullerton with a BA in Psychology and is also a long-time Advisory Board member of the Wharton Center for Human Resources Research Advisory Group of the University of Pennsylvania and Vice Chairman of the Board of the Women’s Business Development Council.

To learn more about CRF Bracket and eClinical technology solutions for eCOA, eConsent, Patient Engagement, IRT, Clinical Supply Management, and Endpoint Quality scientific and data support services, visit www.crfhealth.com and www.bracketglobal.com.

*****************

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world.

To learn more visit www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

CRF Bracket Grows More in 1st Quarter Together than Either Company Achieved Alone in 2018

Pharma industry validates shared vision, strong neuroscience interest, and greater operational scale as robust results illustrate greater than 20% increase in new clinical trial business

PLYMOUTH MEETING, PA – FEBRUARY 26, 2019: CRF Bracket recently closed its first full quarter as a combined business after CRF Health and Bracket merged in September of 2018. With more than a 20% increase in new clinical trial business, that first quarter outpaced either company’s individual performance as a standalone company throughout last year.

This reflects the excitement in the industry, particularly among pharmaceutical companies, for the merger, which brings together complementary proven solutions and scale support teams to deliver a wide suite of eClinical solutions. Sponsors and CROs quickly validated the potential of the new organization, bolstered by significant expansion of strategic relationships with 4 of the top 20 pharmaceutical companies, several new sponsor relationships, and expanded opportunities to partner with CROs. At the same time, CRF Bracket customers see increased value from new market opportunities like eConsent and Patient Engagement.

“Two things surprised me as we brought these businesses together,” said Mike Nolte, CEO of CRF Bracket. “First of all, our teams embraced this with dedication and urgency in a way I’ve never seen before. In fact, engagement has increased and employee turnover has actually decreased since September. At the same time, our customers validated and supported our vision more quickly than I expected, and, while we are not perfect and we know we must deliver, they are collaborating with us actively as we step forward with the belief that we can reshape the future of eClinical technology in clinical trials. Our patient-centric approach aligns with their passion and mission, and together we see the empathetic connection to patients as the rivets that bind our future to faster, more reliable, more consistent clinical research. These are early days, but we are encouraged and humbled by the trust our customers are placing in us to stand alongside them in their important and often life changing work.”

CRF Bracket’s early success is directly connected to growing interest in the intersection of strong clinical capability, from deep roots in neuroscience to capability across the spectrum of therapeutic areas, combined with global reach and a market leading technology and service portfolio that seeks to facilitate the journey of the patient and its link to effective research.

To learn more about CRF Bracket’s solutions for eCOA, eConsent, Patient Engagement, IRT, Clinical Supply Management, and Endpoint Quality scientific and data support services, visit www.crfhealth.com and www.bracketglobal.com.

 

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world. To learn more visit www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

CRF Bracket Moves Clinical Trials Forward at 2019 Annual SCOPE Summit

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference

Plymouth Meeting, PA – February 12, 2019: Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experience. Pharmaceutical companies around the world will convene at the 10th annual Summit of Clinical Operations Executives (SCOPE) 2019, where CRF Bracket executives and subject matter experts will discuss technology and best practices to accomplish these essential goals.

Being held from 18-21 February 2019 in Orlando, Florida, the SCOPE Summit is the foremost collaborative gathering of a wide range of clinical operations leaders, and CRF Bracket will take an active role in driving the conversation – and results for patients worldwide – as more sponsors and CROs continue to place an increasing emphasis on modernizing clinical trials.

As SCOPE 2019 examines advances in all aspects of clinical trial planning, management and operations, CRF Bracket will leverage its uniquely integrated global expertise in eCOA, eConsent, IRT, Clinical Trial Supply Management and Patient Engagement at numerous sessions, roundtables, and panels including…

  • Tuesday, Feb 19 at 12:45 pm:  Oliver Cunningham, Director of Client Enablement, will present ‘Achieving Extended Enterprise Supply Chain Maturity Within a Clinical Supply Environment’ as a deep dive into the potential quality improvements and logistical cost efficiencies at an enterprise level.
  • Thursday, Feb 21 at 1:25 pm – Jeff Lee, President, Patient Engagement and eConsent, will deliver ‘The Secret to Unlock Adoption of eClinical Solutions’, to discuss the value and perceived barriers through an interactive discussion on what else is holding back the large-scale adoption of exciting new technologies.

In addition, CRF Bracket will lead and participate in several roundtables and panel discussions focused on important topics such as implementing electronic informed patient consent (eConsent) and supply chain forecasting and management.

CRF Bracket’s CEO, Mike Nolte, together with a cross-team of subject matter experts, will carry the discussion further at their Booth #415 where they will present strategic opportunities to further transform the patient experience and advance clinical research worldwide.

To begin a conversation with CRF Bracket about how technology can help improve your next trial, schedule a meeting or a demo at SCOPE  or visit http://pages.crfhealth.com/2019_SCOPE.html

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world. To learn more visit www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

Connect with CRF Bracket:

CRF Bracket is a Leading Employer in Romania as Demand for eClinical Solutions Grows

Plymouth Meeting, PA – February 6, 2019:  CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility in the country just two years ago. Celebrating its second anniversary on 6 February since opening its base in lasi, the company’s Romania operation now employs a team of over 200 people in a large office situated in the economic heart of the region and is a leading employer in the area.

CRF Bracket provides life science companies with patient-centric technology for clinical research including electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality analytics and services. In 20 years, the company has delivered solutions to over 4,000 global clinical trials

“Romania is a growing market for bio-science, clinical trials and technology, and our success to date confirms CRF Bracket’s commitment to offering global customers a more extensive range of services, as well as regionalized support from dedicated customer teams,” said Adina Talapaga, VP Global Support Services, CRF Bracket in Romania.  “We have a rich talent pool of highly skilled professionals who all contribute immensely to CRF Bracket’s goal of achieving better clinical trials data and helping to simplify the path to approval for life-changing medicines.”

“If you look at the talent and passion of our teams in Romania, perhaps the rapid growth should not be surprising,” said Mike Nolte, CEO of CRF Bracket.  “Still, the scale of success in such a short time frame is unique. It underscores the industry’s accelerating demand for capable, reliable and talented teams to support eClinical solutions wherever clinical trials are administered. We continue to invest aggressively in building great teams at all of our sites, focused on exceptional service and scale worldwide. In 2019 and beyond, we are confident that lasi will continue to grow as another great hub to support customer success.”

The Romanian site is now a fully integrated part of CRF Bracket’s eClinical solutions business and enables the company to offer its global customers a more extensive range of services, as well as regionalized support. With established teams in both R&D and Operations, the Romanian operation will continue to be supported by CRF Bracket’s wider team based at locations across the US, UK and Finland, demonstrating the company’s continuing commitment to providing customers all over the world with its patient-centric solutions.

*****************

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world.

To learn more visit http://www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

CRF Health and Bracket Announce Merger Closing

Combined company, initially named CRF Bracket, provides Drug Development Companies a Unique Technology and Service Partner for Clinical Research

London, United Kingdom and Wayne, Pennsylvania, USA – September 5, 2018 – CRF Health and Bracket today announced the closing of their merger, bringing together two established clinical research technology leaders. The integrated company, initially named CRF Bracket, provides sponsors and CROs with…

  • Over 20 years of proven patient-centric technology solutions with deep therapeutic area expertise
  • The preeminent eCOA, patient engagement and eConsent solutions
  • Expert rater training, risk based monitoring and data analytics for assessment reliability and consistency
  • Market-leading supply chain solutions to manage research drug delivery from manufacturing to patient

Bracket’s current CEO, Mike Nolte, will assume the role of CEO for the combined company. An experienced leadership team from both organizations will help guide the strategic direction of CRF Bracket, accelerating innovation, scaling a powerful business and staying focused on expert service for customers.

Since 2000, sponsors and CROs of all sizes, including all of the top 20 pharmaceutical companies, have trusted CRF Health and Bracket to support more than 4,000 trials across therapeutic areas.

“These two great teams coming together is a unique moment in this market, and we are moving forward to deliver compelling, dependable patient-centric technology solutions that improve the speed, reliability and insight of clinical research,” said Nolte. “We believe this is an exciting opportunity for our customers and our team, and it creates the foundation of a unified platform with actionable data and insight, highlights a group of unmatched therapeutic area experts, and delivers global scalability. We are just getting started at CRF Bracket, and as we continue to innovate and invest in our combined solutions, we will seek new ways to help our customers bring life-changing therapies to our families and communities around the world.”

David Golde, who leads Genstar’s investment in CRF Bracket, commented, “Genstar is thrilled to be sponsoring the combination of CRF Health and Bracket – two leaders in the clinical research technology industry.  This transformational merger creates an unparalleled set of solutions to help customers conduct clinical trials more efficiently and with a higher probability of success.  This merger also contributes to Genstar’s growing track record of building market-leading companies in the Healthcare industry.”

Philip Russmeyer, Partner at Vitruvian Partners, commented, “We have enjoyed a great partnership with CRF’s world-class management team. CRF Bracket will be a clear global leader in patient-centric clinical research solutions with an outstanding opportunity set, and we congratulate all those involved in a successful combination of the two businesses.”

CRF Bracket was formed by the acquisition of CRF Health from Vitruvian Partners by Genstar Capital (read press release), and by Genstar Capital’s acquisition of Bracket in March 2017 (read press release). To learn more, visit crfhealth.com  or bracketglobal.com.

 

About Bracket

Bracket (bracketglobal.com) is a technology company that accelerates clinical research and improves the experience of patients accessing potentially life-changing therapies. Our solutions, combined with deep scientific and clinical insight, link engaged patients to researchers, provide faster, more reliable decision making, and help provide longer, healthier and more productive lives for our families and communities around the globe. Bracket has over 800 employees and delivers services in more than 90 countries to a diverse base of global customers, including 15 of the top 20 biopharma companies.

 

About CRF Health

CRF Health (crfhealth.com) is the leading global provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, the company delivers best in class, fully integrated eSource solutions for pharma partners. Solutions include TrialMax®, an eCOA suite which consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention, and TrialConsent®, the patient-centered, intuitive and interactive informed eConsent suite.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $10 billion and targets investments focused on targeted segments of the healthcare, financial services, software, and industrial technology industries.

 

About Vitruvian Partners

Vitruvian is a European growth-focused investment firm specialised in ‘dynamic situations’, where companies undergo growth and change typically driven by technology. Vitruvian helps portfolio companies scale their operations by providing an operational support system and assistance with strategic initiatives including acquisitions. Other notable investments to date include global market leaders in their field such as Just Eat, FarFetch, Skyscanner, EasyPark, Snow Software, Trustpilot, Voxbone, Callcredit, Ebury and others. The €2.4bn Vitruvian Investment Partnership III (“VIP III”) is among the largest pools of capital in Europe supporting innovative and higher growth companies. Vitruvian has backed 30 companies in its first two funds and has assets under management of c. €5 billion, operating out of offices in London, Munich, Stockholm, Luxembourg and San Francisco. More information can be found at: www.vitruvianpartners.com

 

Media Contact:

Kristopher E. Sarajian

Vice President, Global Marketing Operations

CRF Bracket

Kristopher.sarajian@bracketglobal.com

Bracket Patient Engagement and eCOA Innovator Jeff Lee Named to PharmaVOICE 100 Most Inspirational People 2018

Founder of mProve Health passionate about improving the patient experience in clinical trials using modern mobile technologies

King of Prussia, PA – Bracket, a technology company providing solutions for better patient outcomes and actionable insights, is honored to announce patient-centric innovator Jeff Lee has been named one of the PharmaVOICE 100 most inspirational people in the life sciences industry. As President, eCOA, Patient Engagement at Bracket, Lee is dedicated to building solutions that deliver an outstanding user experience, transforming the way patients participate in clinical research.

For more than a dozen years, PharmaVOICE magazine has recognized the most inspirational, motivational, and transformational individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue. As always, this year’s distinguished honorees were nominated by thousands of PharmaVOICE readers and were selected for inclusion based on how they inspire others, their positive impact on patients and the industry at large, their innovative thinking, their mentorship to the next generation of leaders, and their willingness to give their time and resources to their communities and philanthropic causes.

“I am humbled and honored to be recognized among such a worthy group of inspiring people by PharmaVOICE, especially because nominations come from clinical operations leaders who use and value our solutions,” said Lee. “It’s crucial to be able to put yourself in the mindset of the patient, the research site, the client, employees – or even business partners. This allows for insight and collaboration that many people just don’t unlock. Empathy is a secret weapon for success.”

Lee founded mProve Health in 2010 to improve the patient experience in clinical trials with a BYOD philosophy that makes it easy for patients to stay invested in the study. mProve quickly became a leading provider of patient engagement and eCOA solutions on mobile devices, and was acquired by Bracket in 2017.

“Jeff’s entrepreneurial spirit, visionary approach, and clinical trial expertise all in pursuit of bringing much-needed treatments to patients epitomize what it means to be a PharmaVOICE 100,” says Taren Grom, editor and co-founder, PharmaVOICE. “In addition, he is an inspirational leader who is lifting his teams to new heights in their pursuit to make a difference in the industry.”

Today, 18 of the top 20 pharmaceutical companies currently use Bracket technology solutions to manage their clinical trials. The company’s patient engagement solutions are designed to help study sponsors and CROs improve retention rates in clinical trials, increase compliance to study protocols, and ensure adherence to therapy.

Lee is listed amongst the commanders and chiefs in the PharmaVOICE 100 issue. Read his full profile here.

About Bracket:

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

 

 

 

Discuss and Determine the Future of eClinRO and Computerized Assessments for Alzheimer’s Disease Research with Bracket at AAIC 2018

Schedule a meeting with Bracket’s expert clinicians and data scientists at AAIC exhibit booth #607 to discover the latest technology for capturing and analyzing reliable clinical trial data

King of Prussia, PA – Attendees at the AAIC 2018 meeting, hosted by the Alzheimer’s Association, are invited to join Bracket to discuss and determine the future of eClinRO and computerized assessments in Alzheimer’s Disease research.

Schedule a meeting to begin a conversation with distinguished clinicians and expert data scientists including Amir Kalali, MD, David Miller, MD, Sarah Karas, PsyD, Todd Feaster, PsyD, Todd M. Solomon, PhD, and Pascal Goetghebeur.

Over the years, Bracket has built deep CNS expertise, including the development of specialized solutions for rater training and certification, quality assurance, and computerized assessments built with a focus on optimizing the patient experience. In particular, the Bracket Rater Station™ is a regulatory-compliant technology that has been used to deliver 45,000 unique scale administrations to over 5,000 patients in more than 60 languages. It is an advanced eClinRO tool that improves interview quality while reducing administration and scoring errors.

Get a demo to gain firsthand experience of Bracket technology, including Rater Station, at AAIC.

In addition to subject matter experts and technology solutions, Bracket will continue to contribute to the scientific discussion with papers and poster sessions at the conference:

  • “Analysis of the Rates and Types of Errors on Enhanced eCOA Versions of the Alzheimer’s Diseases Assessment Scale – Cognitive Subscale and Mini Mental State Examination Used in Clinical Trials of Dementia” presented by first author Solomon at location P1-068 on Sunday, July 22
  • “The Use of Statistical Modeling to Complement Data Quality Programs” presented by first author Karas at location P1-064 on Sunday, July 22
  • “Pilot Validation of an Electronic Alzheimer’s Disease Assessment Scale-Cognitive Subscale” presented by first author Solomon at location P2-035 on Monday, July 23
  • “Electronic ADAS-Cog (eADAS-Cog) Data Quality: How Do Countries Compare?” presented by first author Feaster at location P3-018 on Tuesday, July 24
  • White paper describing the importance of computerized cognitive assessments given new FDA guidance for early AD research by first author Goetghebeur available at Bracket exhibit booth #607

To learn more about Bracket and Alzheimer’s Disease research, begin a conversation at AAIC 2018.

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket

Combined organization will bring together complementary strengths with a shared focus on accelerated customer value through patient-centric clinical technology solutions

LONDON and WAYNE, Pa.July 17, 2018  — Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials. Bracket is a portfolio company of Genstar.

CRF Health has been majority-owned by Vitruvian Partners, a leading growth-and technology-focused investment firm, since 2015.

The newly combined organization will drive accelerated value for pharmaceutical companies and CRO customers, providing patient-centric solutions, combined with deep and broad therapeutic area expertise, across a strong and efficient global footprint.

“CRF Health earned an outstanding reputation with 20 years of experience providing eCOA and now eConsent solutions to the biopharma industry around the world,” said Mike Nolte, who will lead the combined organization as CEO. “CRF’s technology and therapeutic experience dovetail well with our solutions, and they expand our ability to support increasingly complex clinical research. I am excited to bring two outstanding teams together to provide a reliable and scalable platform that accelerates the development of life changing medicines for our families and communities across the globe.”

The combined company will have over 1,500 employees worldwide, and will be in a position to accelerate the penetration of user-friendly technologies across the clinical trial spectrum – driving the transfer from manual, paper based services to electronic while improving service quality and data integrity.

“This is an exciting step forward for patients, clients, and our new combined team,” said Rachel Wyllie, CEO of CRF Health, who will become the Executive Chairman of the combined company. “The complementary nature of the two businesses provides us with the platform and scale for future growth in our dynamic markets, while ensuring our customers have more access to the latest patient-centric innovations in clinical research.”

Jean-Pierre Conte, Chairman and Managing Director at Genstar Capital, added, “Bringing CRF and Bracket together will create a world-class healthcare technology company supporting clinical trials and will accelerate adoption and growth in eCOA, eConsent, patient engagement, rater training and trial supply management solutions. We look forward to working with the outstanding leaders at both organizations. This notable event in pharmaceutical services is another example of Genstar’s private equity strategy of driving change at our portfolio companies to create high-growth and extremely valuable companies. Healthcare is an important sector for Genstar and we continue to identify great opportunities to apply our growth model to build great companies.”

Philip Russmeyer, Partner at Vitruvian Partners, commented, “We are delighted to support the combination of Bracket and CRF to further accelerate, and build upon, the excellent advances that our partnership with the strong management team at CRF has produced over the past years.”

The transaction is expected to be completed by the end of 2018 and is subject to customary closing and regulatory approvals.

Jefferies International Limited served as exclusive financial adviser and Dickson Minto as legal adviser to CRF.  Ropes & Gray LLP served as legal adviser to Genstar Capital.

About Bracket

Bracket (www.bracketglobal.com) is a technology company that accelerates clinical research and improves the experience of patients accessing potentially life-changing therapies. Our solutions, combined with deep scientific and clinical insight, link engaged patients to researchers, provide faster, more reliable decision making, and help provide longer, healthier and more productive lives for our families and communities around the globe. Bracket has over 800 employees and delivers services in more than 90 countries to a diverse base of global customers, including 15 of the top 20 biopharma companies.

About CRF Health

CRF Health is the leading provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® platform consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention. The integrated TrialMax platform includes eCOA solutions for collecting PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), ClinROs (Clinician or Rater Reported Outcomes), and PerfOs (Performance Outcomes), and features TrialConsent®, an electronic solution for collecting and managing informed consent in clinical trials. CRF Health’s eSource solutions improve trial engagement by making the patient the center of the clinical trial process.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $10 billion and targets investments focussed on targeted segments of the healthcare, financial services, software, and industrial technology industries.

About Vitruvian Partners

Vitruvian is a European growth-focused investment firm specialised in ‘dynamic situations’, where companies undergo growth and change typically driven by technology. Vitruvian helps portfolio companies scale their operations by providing an operational support system and assistance with strategic initiatives including acquisitions. Other notable investments to date include global market leaders in their field such as Just Eat, FarFetch, Skyscanner, EasyPark, Snow Software, Trustpilot, Voxbone, Callcredit, Ebury and others. The €2.4bn Vitruvian Investment Partnership III (“VIP III”) is among the largest pools of capital in Europe supporting innovative and higher growth companies. Vitruvian has backed 30 companies in its first two funds and has assets under management of c. €5 billion, operating out of offices in LondonMunichStockholmLuxembourg and San Francisco. More information can be found at: www.vitruvianpartners.com

 

Bracket to Demonstrate Technology that Brings Pharmaceutical Companies Closer to their Patients at DIA Annual Meeting 2018

Visit booth #2522 to improve the patient experience, enable more reliable data capture in clinical trials, and watch (and play) plenty of soccer

King of Prussia, PA – Bracket, a technology company connecting patients to potentially life-changing therapies through faster and more reliable clinical research, will engage with clinical research leaders to showcase solutions that bring pharmaceutical companies closer to their patients at the DIA Annual Meeting in Boston, MA, from June 24-28, 2018.

Exhibit booth #2522 will be an active center for technology demonstrations and insightful conversations with sponsors and CROs determined to improve the patient experience and capture better, more reliable data worldwide.

Schedule a demo to experience the value of Bracket solutions firsthand.

  • Bracket eCOA: A mobile data collection solution that engages patients, caregivers, and clinical site staff. It can be used on provisioned or personal devices and includes robust services for scale management, data management, logistics, and outcomes advisory.
  • Bracket Patient Engagement: A mobile app and reminder system proven to boost patient compliance and study completion. It has been used by 18 of the top 20 pharmaceutical companies to engage research patients around the globe.
  • Bracket Neuroscience: An advanced solution for collecting clinician-rated endpoint data in neurology studies. Its advanced analytics and scientific services improve study data quality by maximizing rater reliability.
  • Bracket IRT & Clinical Supplies: An industry-trusted, quick-deploy solution for managing randomization and clinical supplies. It integrates seamlessly with Bracket SmartSupplies to forecast, label, distribute, manage and reconcile clinical supplies.

Visitors to the Bracket booth will also have the opportunity to share challenges and brainstorm best practices with subject matter experts including distinguished ePRO Consortium member Serge Bodart, Senior Adviser Outcomes Science, and Jeff Lee, President of eCOA and Patient Engagement, the patient technology innovator who founded mProve Health (acquired by Bracket in 2017).

In addition to technology discussions and live solution demonstrations, Bracket will help provide some well-deserved entertainment breaks with opportunities for casual fun:

  • Live viewings of global soccer tournament matches and a free-to-play foosball table
  • Daily raffles for an Amazon Echo Show
  • The “can’t miss” social event of the conference, Bracket’s annual party with CluePoints, this year to be held on Tuesday, June 26, at The Grand nightclub opening at 10pm. RSVP here then pick up your ticket at the Bracket booth.

“We are moving urgently to deliver new, high-impact capabilities for customers,” said Mike Nolte, Bracket CEO. “Inside Bracket, we’re adding even more expert talent to our team and investing in exciting new patient technology offerings built off years of established success. More importantly, we’re focused on connecting researchers and patients to accelerate the quality and speed of clinical trials through active engagement. Our industry has the noble responsibility to support longer and more productive lives for our families and communities around the world, and we are dedicated to supporting their success with great technology that patients love. I’m excited to share some of it with you at DIA.”

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.